Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Research and Innovation Action · Running

SNIP-AFRICA Severe neonatal infection adaptive platform trials in Africa

Coordinator
Fondazione Penta Ets, Italy
Runs
1 July 2023 to 30 June 2028
Status
Running
EU funding
€7.2m
Total cost
€7.2m
Partners
12 organisations in 9 countries
Type
Research and Innovation Action
Grant agreement
101103201

What the project is doing

In the project's own words, from its summary on CORDIS.

SNIP-AFRICA aims to establish a clinical research network and architecture to implement adaptive platform trials in sub-Saharan Africa (SSA), responding to the urgent need for improved treatment of childhood infection in an era of increasing antimicrobial resistance (AMR). SNIP-AFRICA focuses on the high-burden, high-impact group of inpatient neonates and infants with sepsis. This is a group especially affected by escalating rates of AMR in SSA healthcare facilities contributing to much slower than desirable improvements in neonatal mortality across SSA.

The project will address all aspects of APTs in neonatal sepsis from defining potential treatments of interest to translation into clinical guidance, and will deliver interventional studies in the two domains of neonatal dose confirmation and drug regimen selection. The network and architecture could be readily extended to include older children in hospital with infections with epidemic potential. SNIP-AFRICA will achieve its aim by bringing together partners from the global North and SSA, including several with experience in designing and running adaptive platform trials and complex randomised controlled trials in SSA.

The project therefore builds on existing expertise and capacity to enable an innovative response to the major threat to child health of AMR through a new architecture and extended network. The work plan includes Project Management, Coordination and Communication (WP1), Clinical and Microbiological Surveillance (WP2), Adaptive Platform Core Protocol and Governance (WP3), Pharmacokinetics for Adaptive Platform Trial (WP4), Complex Adaptive Drug Regimen Trial (WP5), Training and Capacity building for Adaptive Trials (WP6) and Stakeholder Engagement and Integration (WP7).

SNIP-AFRICA aims to trigger a paradigm shift in interventional research in severe childhood infection and to equip a network of SSA institutions and researchers to conduct innovative, efficient, targeted research in this area.

Topics

Who is involved

OrganisationCityCountryRole
Fondazione Penta EtsPadovaItalyCoordinator
Universiteit AntwerpenAntwerpenBelgiumParticipant
GARDP FoundationGeneveSwitzerlandAssociatedpartner
Universitat ZurichZurichSwitzerlandAssociatedpartner
Kwame Nkrumah University of Science and Technology KumasiKumasiGhanaParticipant
Health Research Operations Kenya LimitedKilifiKenyaParticipant
The Registered Trustees of the Ifakara Health InstituteDar Es SalaamTZParticipant
Mu Jhu Care LimitedKawempe DivisionUGParticipant
St George's Hospital Medical SchoolLondonUnited KingdomParticipant
University College LondonLondonUnited KingdomParticipant
Gardp Africa NpcWestern Cape Cape TownSouth AfricaParticipant
Stellenbosch UniversityStellenboschSouth AfricaParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI